ABOUT FIBROIDS: Fibroids are benign, non-cancerous tumors in a woman’s uterus that often appear during childbearing years. Also called leiomyomas, fibroids are made up of muscle and connective tissue and may range in size from microscopic to larger than a grapefruit. The rate at which they grow is unpredictable, and a woman may have more than one fibroid at a time. While some fibroids are asymptomatic, others can be very painful and cause heavy bleeding, pressure on the bladder or rectum, a distended abdomen, and a lack of energy stemming from anemia. The majority of American women will develop fibroids at some point in their lives. According to the National Institutes of Health (NIH), at least 70 percent of women in the U.S. will develop fibroids by age 50, and the prevalence is even higher among African American women.
ABOUT THE ACESSA PROCEDURE: Acessa is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy fibroids, and relieves symptoms without damaging or removing the uterus. After treatment, the fibroids are re-absorbed by the surrounding tissue. Acessa allows the surgeon to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. Acessa is FDA-cleared for the treatment of symptomatic uterine fibroids.
RISK STATEMENT: Acessa is cleared by the FDA for the treatment of symptomatic uterine fibroids. There are risks associated with all minimally invasive surgical procedures, including serious complications such as infection, bowel injury, and postoperative bleeding. Insufficient data exist on which to evaluate the safety and effectiveness of Acessa procedure in women who plan future pregnancy. Therefore, the Acessa procedure is not recommended for women who are planning future pregnancy. Please consult with an Acessa-trained gynecologist to understand the risks of surgery and find out if Acessa may be right for you.
© Copyright 2019 - Acessa Health